Hogan Lovells 2024 Election Impact and Congressional Outlook Report
Hogan Lovells Events | 07 April 2022 | 9:30 AM - 5:30 PM (EST)
Creation and adoption of artificial intelligence (AI) systems promise better health care management for patients and faster, more accurate diagnoses for doctors. Companies pursuing AI technologies must realize that while the health care industry is embracing this technology, the legal and regulatory landscape is still finding its footing.
Join Hogan Lovells for an informative and interactive program where our thought leaders and industry guests will address a variety of topics including new and emerging health care AI policies and regulatory considerations, implications for ethics and consumer safety, developments in the EU, and more.
Certain sessions were recorded during the program. To view a particular recording, please click on the title from below:
Related articles
Partner
Washington, D.C.
Partner
Washington, D.C.
Senior Associate
London
Partner
Washington, D.C.
Counsel
London
Counsel
London
Partner
London
Partner
Washington, D.C.
Partner
Philadelphia
Kathleen Blake, MD
Senior Advisor, American Medical Association
Kerri Haresign
Director, Technology & Standards, Consumer Technology Association (CTA)
Yuri Maricich, MD
Chief Medical Officer & Head of Development, Pear Therapeutics
Nicole Sweeney
Senior Director, Market Access Strategy & Operations, Tempus Labs
Michael Abramoff, MD
Chair, AI Healthcare Coalition
Jayme Strauss, RN
Chief Clinical Director, Viz.ai
Clark Daniel
Director, Government Relations, HeartFlow
The Honorable Brad Wenstrup
U.S. Representative, R-OH
Richard Frank, MD
Chief Medical Officer, Siemens Healthineers
Anitra Graves
Medical Director, Noridian
Julie Letwat
Head of Government Affairs, iRhythm
The Honorable Suzan DelBene
U.S. Representative, D-WA
Seth Rainford
President & COO, Digital Diagnostics